Entropy Technologies »

Enliven Therapeutics shares owned by Entropy Technologies

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Entropy Technologies from 13F filings

Historical chart of Entropy Technologies investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by Entropy Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by Entropy Technologies

Quarter filed Position value Share count Share price at filing
2026-03-31 $239k 6.1k 39.20

More positions owned by Entropy Technologies

Cheniere Energy Ord Com New (LNG)
Boston Scientific Corporation (BSX)
Costco Wholesale Corporation (COST)
Abbott Laboratories (ABT)
Colgate-Palmolive Company (CL)
FedEx Corporation (FDX)
Chevron Corporation (CVX)
Occidental Petroleum Corporation (OXY)
Lockheed Martin Corporation (LMT)
Medtronic Ord SHS (MDT)
PG&E Corporation (PCG)
Palantir Technologies Cl A Ord Cl A (PLTR)
Blackrock (BLK)
Trane Technologies Ord SHS (TT)
Mastercard Cl A Ord Cl A (MA)

View all positions for Entropy Technologies

Top funds holding Enliven Therapeutics

OrbiMed Advisors
FMR
Polar Capital Holdings
BlackRock
Commodore Capital
Vestal Point Capital
Bellevue Group
Citadel Advisors
Fairmount Funds Management
VR Adviser
Novo A/S
State Street Corporation
Geode Capital Management
Logos Global Management
Caption Management

View all funds holding Enliven Therapeutics